Due to COVID-19 we are now offering TeleHealth Office Visits via video or phone call. Learn More >
We have prepared for the Coronavirus (COVID-19). We have updated policies to protect our patients and staff. Learn more.

Vitamin D May Help To Prevent Progression of Metastatic Colorectal Cancer

The exact causes of colorectal cancer are not known. Research shows that certain risk factors such as obesity, family history, diet, smoking and alcohol consumption can cause colorectal cancer. Colorectal cancer can appear without symptoms, but screening can help detect the disease early.

Screening recommendations for people with low-risk colorectal cancer is from age 50, but those at high risk, such as a history of inflammatory bowel disease should start screening at the age of 40. Because of the high probability of colorectal cancer recurrence, patients should go for regular checkups to prevent any recurrence.

A new study has concluded that high doses of vitamin D can prevent the growth of advanced colorectal cancer when combined with chemotherapy.

In the study,

  • Vitamin D can help slow the progression of metastatic colorectal cancer.
  • The results from the trial are promising and can help determine new treatment possibilities of the disease in future.
  • In the trial, two groups with metastatic colorectal cancer were given high doses of vitamin D and low doses of vitamin D, respectively. Both groups also took standard chemotherapy.
  • It was observed that the progression of the disease in the group with high dose vitamin D stopped after 11 months while the other group had a delay in the progression of the disease in 13 months.
  • It was also discovered that trial participants in the group with high dose vitamin D were not likely to experience the progression of their cancer or death within the follow-up period of 22.9 months.

The trial results suggest that there is a tremendous improvement in the outcomes for the patients who received the vitamin D supplements, indicating that vitamin D has the capability of fighting metastatic colorectal cancer. More research is underway to confirm these findings in a much larger clinical trial.

More Choice Cancer Care Centers